SEC Tracker
Get the app

Bausch Health Companies BHC

Bausch Health Companies (BHC) acquired 10,720 common shares on Sep 30, 2026

John Paulson, insider filing for BHC

Form
4
Filed
Importance
Routine
  1. Reported by Paulson John on Oct 2, 2026
  2. Acquired 10,720 common shares on Sep 30, 2026
  3. Owns 440,962 common shares directly
  4. Indirectly owns 73,255,869 shares via managed funds

Written from the Form 4 on EDGAR. AI can make mistakes. Check the filing.

Open in the appGet the appView on EDGAR

Get an email when Bausch Health Companies files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Recursion Pharmaceuticals RXRX public float $2.0B, Jun 30, 2025
  2. Agios Pharmaceuticals AGIO public float $1.9B, Jun 30, 2025
  3. Vericel VCEL public float $2.1B, Jun 30, 2025
  4. Biocryst Pharmaceuticals BCRX public float $1.9B, Jun 30, 2025
  5. Indivior Pharmaceuticals INDV public float $1.8B, Jun 30, 2025